Market Closed -
Other stock markets
|
Pre-market 09:10:03 am | |||
1.12 USD | +14.92% | 1.115 | -0.45% |
May. 09 | Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 06 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.84% | 216M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.56% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Earnings Flash (BLUE) BLUEBIRD BIO Reports Q1 Revenue $2.4M, vs. Street Est of $27M